Reference
Kouwenberg CV, et al. Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis. Acta Ophthalmologica 100: e994-e1001, No. 4, Jun 2022. Available from: URL: http://doi.org/10.1111/aos.15012
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1912, 17 (2022). https://doi.org/10.1007/s40278-022-17720-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-17720-2